Siegfried Holding AG (LON:0QQO)
London
· Delayed Price · Currency is GBP · Price in CHF 96.90
+2.40 (2.54%)
At close: Apr 29, 2025
Siegfried Holding AG Revenue
In the year 2024, Siegfried Holding AG had annual revenue of 1.29B CHF with 1.82% growth. Siegfried Holding AG had revenue of 674.67M in the half year ending December 31, 2024, with 4.96% growth.
Revenue
1.29B CHF
Revenue Growth
+1.82%
P/S Ratio
3.42
Revenue / Employee
333.14K CHF
Employees
3,886
Market Cap
3.90B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.29B | 23.08M | 1.82% |
| Dec 31, 2023 | 1.27B | 41.98M | 3.41% |
| Dec 31, 2022 | 1.23B | 127.10M | 11.53% |
| Dec 31, 2021 | 1.10B | 257.36M | 30.45% |
| Dec 31, 2020 | 845.06M | 11.55M | 1.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Siegfried Holding AG News
- 2 months ago - Siegfried Holding AG (XSWX:SFZN) Full Year 2024 Earnings Call Highlights: Strong Profit Growth ... - GuruFocus